We are live on ! Find out more
SWAV

Shockwave Medical, Inc. Common Stock

Delisted

SWAV was delisted on the 30th of May, 2024.

7 hedge funds and large institutions have $1.93M invested in Shockwave Medical, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 475 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

99% less funds holding

Funds holding: 4887 (-481)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 475

100% less capital invested

Capital invested by funds: $12B → $1.93M (-$12B)

100% less funds holding in top 10

Funds holding in top 10: 150 (-15)

Holders
7
Holders Change
-481
Holders Change %
-98.57%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
2
Reduced
3
Closed
475
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
51
Goldman Sachs
New York
-$58.4M -179,235 Closed
Neuberger Berman Group
52
Neuberger Berman Group
New York
-$58.2M -178,880 Closed
JJ
53
Johnson & Johnson
New Jersey
-$54.3M -166,812 Closed
FLAM
54
First Light Asset Management
Minnesota
-$52.6M -161,484 Closed
ClearBridge Investments
55
ClearBridge Investments
New York
-$52.3M -160,605 Closed
WCM Investment Management
56
WCM Investment Management
California
-$51.4M -157,800 Closed
Marshall Wace
57
Marshall Wace
United Kingdom
-$50.4M -154,801 Closed
Adage Capital Partners
58
Adage Capital Partners
Massachusetts
-$48.8M -150,000 Closed
Axa
59
Axa
France
-$46.4M -142,510 Closed
Principal Financial Group
60
Principal Financial Group
Iowa
-$45.4M -139,482 Closed
RSCM
61
Rock Springs Capital Management
Maryland
-$44M -135,000 Closed
TAL
62
TIG Advisors LLC
New York
-$42.6M -130,744 Closed
N
63
Nuveen
North Carolina
-$40.9M -125,657 Closed
Thrivent Financial for Lutherans
64
Thrivent Financial for Lutherans
Minnesota
-$38.3M -117,561 Closed
Massachusetts Financial Services
65
Massachusetts Financial Services
Massachusetts
-$37.9M -116,484 Closed
Nomura Holdings
66
Nomura Holdings
Japan
-$37.8M -116,188 Closed
ACM
67
Atika Capital Management
New York
-$37.3M -114,500 Closed
Loomis, Sayles & Company
68
Loomis, Sayles & Company
Massachusetts
-$35.8M -109,942 Closed
Bank of Montreal
69
Bank of Montreal
Ontario, Canada
-$35.3M -108,066 Closed
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
-$34.6M -106,301 Closed
BG
71
Bellevue Group
Switzerland
-$34.4M -105,786 Closed
FTM
72
First Turn Management
California
-$31.9M -98,111 Closed
AIM
73
Artemis Investment Management
United Kingdom
-$28.1M -86,420 Closed
SO
74
STRS Ohio
Ohio
-$27.7M -85,000 Closed
EP
75
Eversept Partners
New York
-$26.2M -80,555 Closed

SWAV Hedge Fund Activity: Q2 2024 in Review

7 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q2 2024, worth a combined $1.93M — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 475 funds closed out of SWAV and 1 opened new positions — a net loss of 474 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Blue Trust Inc, adding an estimated $52K. The largest seller was BlackRock, exiting entirely with an estimated $1.23B sold.

  • 7 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q2 2024, down from 488 in Q1 2024.
  • Funds reported $1.93M of Shockwave Medical, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 1 fund opened new Shockwave Medical, Inc. Common Stock positions in Q2 2024 and 475 closed out, a net change of -474 holders.
  • The largest Shockwave Medical, Inc. Common Stock buyer in Q2 2024 was Blue Trust Inc, an estimated $52K added.
  • The largest Shockwave Medical, Inc. Common Stock seller in Q2 2024 was BlackRock, an estimated $1.23B sold.

Based on aggregated 13F filings for Q2 2024.